Trade Bolt Biotherapeutics, Inc. - BOLT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0122 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.6471 |
| Open | 0.6523 |
| 1-Year Change | -40.53% |
| Day's Range | 0.6372 - 0.6523 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | 0.6382 | -0.0141 | -2.16% | 0.6523 | 0.6584 | 0.6372 |
| Sep 5, 2024 | 0.6471 | -0.0121 | -1.84% | 0.6592 | 0.6601 | 0.6471 |
| Sep 4, 2024 | 0.6571 | -0.0101 | -1.51% | 0.6672 | 0.6673 | 0.6571 |
| Sep 3, 2024 | 0.6672 | -0.0076 | -1.13% | 0.6748 | 0.6775 | 0.6672 |
| Aug 30, 2024 | 0.6725 | -0.0088 | -1.29% | 0.6813 | 0.6868 | 0.6672 |
| Aug 29, 2024 | 0.6819 | 0.0147 | 2.20% | 0.6672 | 0.6862 | 0.6672 |
| Aug 28, 2024 | 0.6775 | 0.0003 | 0.04% | 0.6772 | 0.6873 | 0.6761 |
| Aug 27, 2024 | 0.6787 | 0.0015 | 0.22% | 0.6772 | 0.6873 | 0.6772 |
| Aug 26, 2024 | 0.6771 | -0.0077 | -1.12% | 0.6848 | 0.6849 | 0.6771 |
| Aug 23, 2024 | 0.6846 | 0.0022 | 0.32% | 0.6824 | 0.6873 | 0.6772 |
| Aug 22, 2024 | 0.6839 | -0.0033 | -0.48% | 0.6872 | 0.6885 | 0.6823 |
| Aug 21, 2024 | 0.6872 | 0.0090 | 1.33% | 0.6782 | 0.6882 | 0.6782 |
| Aug 20, 2024 | 0.6868 | 0.0086 | 1.27% | 0.6782 | 0.6924 | 0.6782 |
| Aug 19, 2024 | 0.6879 | 0.0057 | 0.84% | 0.6822 | 0.6925 | 0.6822 |
| Aug 16, 2024 | 0.6863 | 0.0081 | 1.19% | 0.6782 | 0.6897 | 0.6782 |
| Aug 15, 2024 | 0.6882 | 0.0000 | 0.00% | 0.6882 | 0.6982 | 0.6882 |
| Aug 14, 2024 | 0.6872 | 0.0000 | 0.00% | 0.6872 | 0.6920 | 0.6871 |
| Aug 13, 2024 | 0.6923 | 0.0051 | 0.74% | 0.6872 | 0.7070 | 0.6872 |
| Aug 12, 2024 | 0.6972 | 0.0015 | 0.22% | 0.6957 | 0.7041 | 0.6872 |
| Aug 9, 2024 | 0.6978 | 0.0021 | 0.30% | 0.6957 | 0.7028 | 0.6957 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Bolt Biotherapeutics, Inc. Company profile
About Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc is a clinical-stage immuno-oncology company. The Company is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Its Immune-Stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells, including macrophages and dendritic cells, that kill tumor cells via phagocytosis and expose tumor neoantigens to the adaptive immune system. The Company’s product candidate BDC-1001 is a human epidermal growth factor receptor 2 (HER2) Boltbody ISAC comprised of a HER2-targeting biosimilar, of trastuzumab conjugated to one of its TLR7/8 agonists, for the treatment of patients with HER2-expressing solid tumors, including those with HER2-low tumors. Its Toll-like receptors (TLRs) activate myeloid cells and enable the presentation of tumor-associated neoantigens to cytotoxic T cells.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Bolt Biotherapeutics Inc revenues increased from $231K to $752K. Net loss increased from $29.7M to $71.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and d increase of 99% to $49.8M (expense), Fair Value Adjustments on Other Assets decrease from $2.4M (income) to $6.1M (expense).
| Industry: | Bio Therapeutic Drugs |
900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US
News
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com